SWL: Our twenty-four year experience

Giampaolo Zanetti, Alberto Trinchieri, Emanuele Montanari, Francesco Rocco

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Treatment of renal and ureteral stones by SWL has been proved safe and effective in the last 25 years. We reviewed our twenty-four year experience, which began in January 1985 with an original HM3 Dornier lithotripter and has continued along the years with second and multifunctional third generation lithotripters. Dysrhythmias occurred almost exclusively in stone kidney treatments and never in distal ureteral ones. No significant correlation was found between the side of the treated kidney, the number and strength of shockwaves, or the administration of analgesics and the occurrence of dysrhythmia. SWL without ECG triggering was not associated with the occurrence of dysrhythmic episodes of any particular clinical significance. We followed for an average of 42 months patients treated with SWL for different types of stones. At discharge, 31.5% of the patients were stone free, whereas 65.3% had stone dust or passable fragments. At three-month follow-up, 64.8% were stone free and 33.6% had dust or passable fragments. After a follow-up of over 24 months, 55% of the patients were still stone free, recurrence was observed in 13.8% and regrowth of fragments in 22.3% of the patients. Small fragments less than 5 mm are defined as clinically insignificant residual fragments (CIRF); although they are likely to pass spontaneously and remain asymptomatic, they are considered by some authors a factor that favours regrowth and an increased risk for symptomatic episodes. Patients with fragments in our experience do not require systematic retreatment but they could be followed and treated if necessary if stones recur or symptoms persist. Most of the CIRF pass spontaneously after treatment without any complication, but since about 20% of patients become symptomatic or require intervention, a close follow-up is required. Extracorporeal shock wave lithotripsy is the first choice treatment today for most renal and ureteral stones, however adequate evaluation of the patient and of the stone is required, and all possible treatment options should be considered.

Original languageEnglish
Pages (from-to)21-26
Number of pages6
JournalArchivio Italiano di Urologia e Andrologia
Volume80
Issue number1
Publication statusPublished - Mar 2008

Fingerprint

Dust
Kidney
Therapeutics
Retreatment
Kidney Calculi
Lithotripsy
Analgesics
Electrocardiography
Recurrence

Keywords

  • Lithotripsy
  • Stone fragments
  • SWL

ASJC Scopus subject areas

  • Nephrology
  • Urology

Cite this

Zanetti, G., Trinchieri, A., Montanari, E., & Rocco, F. (2008). SWL: Our twenty-four year experience. Archivio Italiano di Urologia e Andrologia, 80(1), 21-26.

SWL : Our twenty-four year experience. / Zanetti, Giampaolo; Trinchieri, Alberto; Montanari, Emanuele; Rocco, Francesco.

In: Archivio Italiano di Urologia e Andrologia, Vol. 80, No. 1, 03.2008, p. 21-26.

Research output: Contribution to journalArticle

Zanetti, G, Trinchieri, A, Montanari, E & Rocco, F 2008, 'SWL: Our twenty-four year experience', Archivio Italiano di Urologia e Andrologia, vol. 80, no. 1, pp. 21-26.
Zanetti G, Trinchieri A, Montanari E, Rocco F. SWL: Our twenty-four year experience. Archivio Italiano di Urologia e Andrologia. 2008 Mar;80(1):21-26.
Zanetti, Giampaolo ; Trinchieri, Alberto ; Montanari, Emanuele ; Rocco, Francesco. / SWL : Our twenty-four year experience. In: Archivio Italiano di Urologia e Andrologia. 2008 ; Vol. 80, No. 1. pp. 21-26.
@article{39889d710a44425fbf0302a69d04e1b9,
title = "SWL: Our twenty-four year experience",
abstract = "Treatment of renal and ureteral stones by SWL has been proved safe and effective in the last 25 years. We reviewed our twenty-four year experience, which began in January 1985 with an original HM3 Dornier lithotripter and has continued along the years with second and multifunctional third generation lithotripters. Dysrhythmias occurred almost exclusively in stone kidney treatments and never in distal ureteral ones. No significant correlation was found between the side of the treated kidney, the number and strength of shockwaves, or the administration of analgesics and the occurrence of dysrhythmia. SWL without ECG triggering was not associated with the occurrence of dysrhythmic episodes of any particular clinical significance. We followed for an average of 42 months patients treated with SWL for different types of stones. At discharge, 31.5{\%} of the patients were stone free, whereas 65.3{\%} had stone dust or passable fragments. At three-month follow-up, 64.8{\%} were stone free and 33.6{\%} had dust or passable fragments. After a follow-up of over 24 months, 55{\%} of the patients were still stone free, recurrence was observed in 13.8{\%} and regrowth of fragments in 22.3{\%} of the patients. Small fragments less than 5 mm are defined as clinically insignificant residual fragments (CIRF); although they are likely to pass spontaneously and remain asymptomatic, they are considered by some authors a factor that favours regrowth and an increased risk for symptomatic episodes. Patients with fragments in our experience do not require systematic retreatment but they could be followed and treated if necessary if stones recur or symptoms persist. Most of the CIRF pass spontaneously after treatment without any complication, but since about 20{\%} of patients become symptomatic or require intervention, a close follow-up is required. Extracorporeal shock wave lithotripsy is the first choice treatment today for most renal and ureteral stones, however adequate evaluation of the patient and of the stone is required, and all possible treatment options should be considered.",
keywords = "Lithotripsy, Stone fragments, SWL",
author = "Giampaolo Zanetti and Alberto Trinchieri and Emanuele Montanari and Francesco Rocco",
year = "2008",
month = "3",
language = "English",
volume = "80",
pages = "21--26",
journal = "Archivio Italiano di Urologia Nefrologia Andrologia",
issn = "1120-8538",
publisher = "Edizioni Scripta Manent s.n.c.",
number = "1",

}

TY - JOUR

T1 - SWL

T2 - Our twenty-four year experience

AU - Zanetti, Giampaolo

AU - Trinchieri, Alberto

AU - Montanari, Emanuele

AU - Rocco, Francesco

PY - 2008/3

Y1 - 2008/3

N2 - Treatment of renal and ureteral stones by SWL has been proved safe and effective in the last 25 years. We reviewed our twenty-four year experience, which began in January 1985 with an original HM3 Dornier lithotripter and has continued along the years with second and multifunctional third generation lithotripters. Dysrhythmias occurred almost exclusively in stone kidney treatments and never in distal ureteral ones. No significant correlation was found between the side of the treated kidney, the number and strength of shockwaves, or the administration of analgesics and the occurrence of dysrhythmia. SWL without ECG triggering was not associated with the occurrence of dysrhythmic episodes of any particular clinical significance. We followed for an average of 42 months patients treated with SWL for different types of stones. At discharge, 31.5% of the patients were stone free, whereas 65.3% had stone dust or passable fragments. At three-month follow-up, 64.8% were stone free and 33.6% had dust or passable fragments. After a follow-up of over 24 months, 55% of the patients were still stone free, recurrence was observed in 13.8% and regrowth of fragments in 22.3% of the patients. Small fragments less than 5 mm are defined as clinically insignificant residual fragments (CIRF); although they are likely to pass spontaneously and remain asymptomatic, they are considered by some authors a factor that favours regrowth and an increased risk for symptomatic episodes. Patients with fragments in our experience do not require systematic retreatment but they could be followed and treated if necessary if stones recur or symptoms persist. Most of the CIRF pass spontaneously after treatment without any complication, but since about 20% of patients become symptomatic or require intervention, a close follow-up is required. Extracorporeal shock wave lithotripsy is the first choice treatment today for most renal and ureteral stones, however adequate evaluation of the patient and of the stone is required, and all possible treatment options should be considered.

AB - Treatment of renal and ureteral stones by SWL has been proved safe and effective in the last 25 years. We reviewed our twenty-four year experience, which began in January 1985 with an original HM3 Dornier lithotripter and has continued along the years with second and multifunctional third generation lithotripters. Dysrhythmias occurred almost exclusively in stone kidney treatments and never in distal ureteral ones. No significant correlation was found between the side of the treated kidney, the number and strength of shockwaves, or the administration of analgesics and the occurrence of dysrhythmia. SWL without ECG triggering was not associated with the occurrence of dysrhythmic episodes of any particular clinical significance. We followed for an average of 42 months patients treated with SWL for different types of stones. At discharge, 31.5% of the patients were stone free, whereas 65.3% had stone dust or passable fragments. At three-month follow-up, 64.8% were stone free and 33.6% had dust or passable fragments. After a follow-up of over 24 months, 55% of the patients were still stone free, recurrence was observed in 13.8% and regrowth of fragments in 22.3% of the patients. Small fragments less than 5 mm are defined as clinically insignificant residual fragments (CIRF); although they are likely to pass spontaneously and remain asymptomatic, they are considered by some authors a factor that favours regrowth and an increased risk for symptomatic episodes. Patients with fragments in our experience do not require systematic retreatment but they could be followed and treated if necessary if stones recur or symptoms persist. Most of the CIRF pass spontaneously after treatment without any complication, but since about 20% of patients become symptomatic or require intervention, a close follow-up is required. Extracorporeal shock wave lithotripsy is the first choice treatment today for most renal and ureteral stones, however adequate evaluation of the patient and of the stone is required, and all possible treatment options should be considered.

KW - Lithotripsy

KW - Stone fragments

KW - SWL

UR - http://www.scopus.com/inward/record.url?scp=42449124171&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=42449124171&partnerID=8YFLogxK

M3 - Article

C2 - 18533621

AN - SCOPUS:42449124171

VL - 80

SP - 21

EP - 26

JO - Archivio Italiano di Urologia Nefrologia Andrologia

JF - Archivio Italiano di Urologia Nefrologia Andrologia

SN - 1120-8538

IS - 1

ER -